News About: Pharm. Industry
Chong Kun Dang, Jinyang increase their collaboration for new premature ejaculation drug
Chong Kun Dang Pharmaceutical and Jinyang Pharmaceutical announced Monday that both companies has signed an agreement to extend their collaboration for Jinyang’s new premature ejaculation treatment containing clomipra...
Korea's biggest drug exhibition kicks off Tuesday
The Korea Pharm 2013, the nation’s largest drug exhibition, opened at 2 p.m. May 28 for a four-day run at KINTEX in Goyang, Gyeonggi Province.
Over 200 foreign buyers and 83 enterprises are expected to participate ...
Novartis Korea draws fire
Novartis Korea’s immorality is under severe criticism from the domestic pharmaceutical industry as the company has recently announced its plan to suspend Glivec’s patient assistance program once generic drugs enter th...
20 modified versions of older drugs approved in 4 years
A total of 20 prescription drugs approved by the Ministry of Food and Drug Safety (MFDS) between 2009 and 2012 were modified versions of existing medicines, or identical to drugs already on the market.
According to...
Drug makers call for realistic support
Pharmaceutical firms are calling for the government to provide them with more practical and realistic support, criticizing too many restrictions on the industry.
Without such efforts, the government’s plan for Kore...
Korean drugmakers challenge Glivec in generics fight
Korean pharmaceutical firms are gearing up to enter the 100 billion won leukemia drug market as the main patent of the market leader, Novartis’s Glivec (imatinib), is to expire on June 3, allowing for generic versions...
14 drugmakers shell out 37.5 billion won in new broadcasting media
Korea’s fourteen pharmaceutical companies have been spending on the four new general programming channels and other broadcasting media that debuted in late 2011.
Citing the 2013 business report released by the Fina...
Dong-A’s illegal kickbacks revealed
A former employee of Dong-A Pharmaceutical testified in Monday’s court hearing that he had offered the illegal rebate of 2.4 million won to a doctor per a 15-minute educational video in an effort to prescribe or sell ...
Drugmakers call for pro-R&D policies
The domestic pharmaceutical industry may become one of the new growth engines for the Korean economy, but it there are still many challenges to overcome, such as a lack of incentives to attract domestic and foreign ph...
Three persons to face testimony over Dong-A’s illegal kickbacks
The Seoul Central District Court will call three witnesses in testimony today in its third trial in a bid to examine whether some doctors, who allegedly took kickbacks from Dong-A Pharmaceutical, received money in ret...
